Up to is doing a lot of quiet work in that sentence.
You've read the dollar figure before.
Trusting one smooth cycle to predict the next fell short.
So did saying yes to each bigger offer.
Here are five truths to decode before you sign again.
1. "Up to" names a ceiling and says nothing about the floor
Up to $10,000 tells you the most you could be paid.
It says nothing about the least.
Recruitment copy gives no clear answer on what it guarantees if a cycle is cancelled partway through.
Donors are often told pay is per donation, not per egg.
They aren't told clearly what changes when fewer eggs come out.
So ask for the floor, and ask for it in writing.
Ask what you're paid if you stop after the first injection.
Ask what you're paid if you're medically disqualified after starting medication.
Ask what you're paid if retrieval happens and the yield is low.
A vague answer tells you what "up to" is really covering.
Even a clear floor won't tell you what lands in your account.
2. The number on the page is not the number in your account
One donor learned midway through her contract that per diems were only $50 to $75 a day.
Travel then ate into the promised total.
Another found out after signing that her pay was taxable.
She ended up doing another donation just to cover the tax bill.
Then there's time.
Two weeks became eight weeks or more for some donors.
Nobody agrees on what counts toward a cap either.
Travel, per diems, insurance, and expenses may or may not sit inside that $10,000.
So two offers with the same headline can't be compared.
One donor was promised $10,000 within 90 days.
She says she still wasn't paid five months later.
Ask for your net after taxes, travel, and lost wages.
Ask for the payment date in writing.
Your down payment math depends on both.
And the money isn't the only thing a contract can hold over you once you start.
3. Once medication starts, the wording decides who owes whom
One donor backed out before any injections began.
Her agency billed her $3,400 for "screening and exam costs."
The dispute hinged on whether medication had technically begun.
The agency dropped the bill only after she pushed back.
Another donor who withdrew was threatened with legal action and got repeated harassing calls.
Others report being reminded how much the intended parents had already spent.
That reminder is a pressure tool, whatever it's called.
So read the withdrawal clause with the same care you give the pay clause.
Ask exactly when "begun" counts.
Ask what you owe at each stage if you stop.
Get those answers before the first injection, not after.
Then look at the part of the offer that keeps climbing, because it's pricing something.
4. A rising "up to" is a premium for risk, not a reward
Your fee climbed from $6,000 to $10,000.
For other donors it tripled, because they were now "proven."
One donor was offered $25,000 for a fourth cycle.
The offer was framed as a reward.
It wasn't framed as a reflection of rising risk.
That is what proven really costs.
The price goes up while the cumulative risk goes up with it.
ASRM's six-cycle limit exists because of that cumulative risk.
Some donors still chase a fifth and sixth cycle at $30,000 to $50,000 and beyond.
A smooth first cycle doesn't predict the rest.
One donor's abdomen swelled to "the size of a basketball" after her second donation.
Walking was difficult.
Another spent four days in intensive care after a second retrieval of 53 eggs.
A case manager told one donor hyperstimulation "had never happened" at that clinic.
Weeks later it happened to her.
One agency's material says serious OHSS is "less than 2%."
A researcher's donor data shows critical, hospitalization-level cases.
"No known long-term risk" is technically true because no long-term studies exist.
Nobody looked, so nothing was found.
So who is supposed to stop the offers from climbing?
5. Nobody is enforcing the ceiling, so the call is yours
ASRM's $10,000 guidance was a non-binding recommendation.
It was later withdrawn after a legal challenge.
One agency says it caps pay at $10,000 and calls $100,000 offers "incredibly rare."
Other reporting suggests such sums circulate regularly.
Nobody can verify either claim.
So you might think: if ASRM's own limits don't stop agencies from offering me more, why should I be the one to say no?
Because nobody else in this transaction has your health as the whole point.
You don't even have to say no.
You only need to say "not until it's in writing."
Ads carry the same gap.
One study found 86.4% don't mention OHSS and 83.5% don't mention long-term risks.
Eight of 11 ads offering over $20,000 targeted women under 21.
If a flyer or a TikTok can advertise it, that doesn't mean anyone disclosed the risks.
Advertised everywhere doesn't mean disclosed anywhere.
One donor turned down $80,000 to $100,000 per cycle.
The money seemed disproportionate to the undisclosed risk.
Ask the agency for the floor, the net, the withdrawal line, and the cycle limit.
Then ask how many cycles is too many, and watch how long the answer takes.